2014
DOI: 10.1002/ejoc.201402238
|View full text |Cite
|
Sign up to set email alerts
|

From Glycopeptides to Glycopeptoids

Abstract: This review covers the published literature describing the synthesis of glycopeptoids, a family of glycopeptide mimics. Members of this family are composed of an N‐substituted glycine or β‐alanine oligomer backbone linked to one or several carbohydrate moieties at the amide nitrogen atoms. The interest in this class of biomimetics lies in their enhanced proteolytic stability and greater conformational flexibility relative to glycopeptides. This Microreview not only describes the different methods for synthesis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 76 publications
(51 reference statements)
0
11
0
Order By: Relevance
“…Cyclopeptoids appear as ideal tools to both push and precisely probe the limits of multivalent effects . In contrast to most scaffolds, they indeed offer synthetic flexibility, allowing the access to clusters with finely incremented valencies . Another challenge associated with high‐valency systems is that steric crowding of neighboring ligands may limit the multivalent glycosidase binding .…”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation
“…Cyclopeptoids appear as ideal tools to both push and precisely probe the limits of multivalent effects . In contrast to most scaffolds, they indeed offer synthetic flexibility, allowing the access to clusters with finely incremented valencies . Another challenge associated with high‐valency systems is that steric crowding of neighboring ligands may limit the multivalent glycosidase binding .…”
Section: Figurementioning
confidence: 99%
“…[12,13] In contrastt om ost scaffolds,t hey indeed offer synthetic flexibility,a llowing the access to clusters with finely incremented valencies. [14,15] Another challenge associated with high-valency systems is that steric crowding of neighboring ligands may limit the multivalent glycosidase binding. [10,11,16] This effect was expected to be overcome by the fact that, in the designed cyclopeptoid-based clusters, the scaffold size grows with the valency (Scheme1).…”
mentioning
confidence: 99%
“…Besides being promising antimicrobial agents, peptoids with activity against fungi [ 148 ], Candida biofilm [ 149 ], tuberculosis [ 150 ], the neglected tropical disease leishmaniasis [ 151 ], and cancer cells [ 152 ] have been reported. Peptoids have also found applications within supra- and macromolecular engineering [ 153 ], biomaterials [ 145 ], protein peptoid mutagenesis [ 154 ], and as fluorescent analogs for study of delivery to the cell nucleus [ 155 ], Huntington’s disease [ 156 ], positron emission tomography (PET) [ 157 ], glycopeptoids [ 158 ], DNA-binding peptoids [ 159 ], and carboxyalkyl peptoid PNAs [ 160 ].…”
Section: Peptidomimeticsmentioning
confidence: 99%
“…Indeed, linear peptides usually show low metabolic stability limiting their use as drugs and display conformational flexibility reducing the strength of the ligand-target binding. [1][2][3][4][5][6] Therefore, the development of original cyclopeptide-based therapeutics is currently a growing interest. Some of them like the wellknown vancomycin and its derivatives, [6,7] gramicidin, [8,9] colistin, [10] octreotide, [11] and RGD (Arg-Gly-Asp) derivatives [12,13] exhibit useful biological properties as antibiotics, anticancer drugs and integrin inhibitors.…”
Section: Introductionmentioning
confidence: 99%
“…Cyclic peptides are naturally occurring substances exhibiting improved properties compared to the linear ones. Indeed, linear peptides usually show low metabolic stability limiting their use as drugs and display conformational flexibility reducing the strength of the ligand‐target binding . Therefore, the development of original cyclopeptide‐based therapeutics is currently a growing interest.…”
Section: Introductionmentioning
confidence: 99%